EarningsQ2 2026 Earnings Report
DE:OLN Q2 2026 EPS Results
Actual EPS€0.06
Consensus EPS€0.11
Beat/MissMissed by -€0.06
One Year Ago EPS€0.05
DE:OLN Q2 2026 Revenue Results
Actual Revenue€1.52B
Expected Revenue€1.57B
Beat/MissMissed by -€55.72M
YoY Revenue Growth-0.93%
Earnings Announcement Details
QuarterQ2 2026
Date07/30/2026
TimeAfter Close
Conference CallThursday, July 30, 2026
DE:OLN Upcoming Earnings
Olin's next earnings date is estimated for October 22, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:OLN Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized several positive strategic and operational developments — notably the planned Huntsman merger (creating a ~$12 billion business with $400 million of synergies), epoxy returning to profitability with >$50 million/year of structural cost reductions, meaningful Beyond250 cost savings momentum, improved Winchester commercial trends, and a solid liquidity position ($1.2 billion). Offsetting these positives are near-term headwinds: an unplanned Freeport outage that reduced Q2 EBITDA by $40 million (with an estimated $20 million Q3 impact), a working capital build and legacy litigation cash payments (~$195 million total) pushing expected leverage to ~4.5x at year-end, weak epoxy demand in Europe and a FIFO cost headwind in Q3, and ongoing geopolitical/market volatility that widened guidance. On balance, management conveyed confidence in long-term outlook, strong cost discipline, and cash generation, while acknowledging meaningful short-term uncertainty and balance sheet pressure from litigation payments.Company Guidance
Planned Merger with Huntsman
Announced merger creating a vertically integrated, North American-focused chemical leader with more than $12 billion in sales; definitive proxy filed July 13; special shareholder meeting scheduled for August 25; expected to realize $400 million of synergies quickly after close (expected in H1 2027).
Epoxy Business Recovery and Cost Reductions
Epoxy posted its best results in more than 3 years and returned to positive earnings; implemented price increases to offset raw material and transportation cost increases; structural epoxy cost reductions exceed $50 million per year (Stade supply agreements + Guarulhos plant closure).
Beyond250 Cost Savings Momentum
Beyond250 delivering structural cost reductions; targeting ~ $100 million of incremental structural cost savings in 2026 and management increasingly confident it will exceed the $250 million target by 2028.
Winchester Commercial Recovery and Cost Actions
Commercial ammunition sales improved year-over-year, pricing initiatives implemented to offset rising copper and brass costs, domestic and international military sales remain strong; $30 million Winchester cost-out target largely achieved with potential to exceed as Lake City improvements continue; Q3 seasonality expected to drive sequential earnings improvement.
Strong Liquidity and Capital Allocation Discipline
Available liquidity of $1.2 billion (including undrawn revolver); no bond maturities before 2029; 2026 capital spending targeted at approximately $200 million focused on safe, reliable operations; intention to continue uninterrupted quarterly dividends and use excess cash flow to reduce debt.
Operational and Safety Improvements
Delivered record safety performance in 2026, streamlining work processes, creating reliability roadmaps, adding resources for execution, and leveraging digital tools and AI to identify inefficiencies, reduce costs, and improve asset reliability.
Chlor-Alkali / Vinyls Pricing and Market Dynamics (Q2 Bright Spots)
Caustic soda and EDC export pricing were Q2 bright spots driven by supply chain disruptions; merchant chlorine sales improved seasonally (support from water treatment, refrigerants and derivatives); management expects supply tightening in Q4 due to higher feedstock/energy costs and planned industry shutdowns.
Near-Term EBITDA Guidance
Management provided an overall adjusted EBITDA outlook for Q3 in a range of $100 million to $200 million, with Chemicals expected to be relatively flat sequentially and a modest improvement at Winchester.
Proven Cash Generation at Current Earnings Levels
Management noted trailing performance: trailing adjusted EBITDA referenced (~$5.70) and approximately $100 million of levered free cash flow generated over the last trailing four quarters, used to fund litigation payments while still supporting dividends and capital spending.
DE:OLN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed